ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
August 04, 2022 20:33 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
July 26, 2022 08:00 ET
|
ProPhase Labs, Inc.
Company also provides additional information on ProPhase BioPharma Garden City, NY, July 26, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and...
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022 18:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
July 21, 2022 08:30 ET
|
ProPhase Labs, Inc.
Confirms Quarterly Growth continues year-over-year Announces significant progress being made in Genomics Business Company to Host Live Webcast to Discuss Business Developments Today at 11:30...
ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022
July 19, 2022 08:30 ET
|
ProPhase Labs, Inc.
Garden City, NY, July 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday,...
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology
June 28, 2022 08:30 ET
|
ProPhase Labs, Inc.
Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds Equivir and Equivir G Garden City, NY, June 28, 2022 (GLOBE...
ProPhase Labs Announces Significant Laboratory Expansion
June 13, 2022 08:30 ET
|
ProPhase Labs, Inc.
Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a...
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
May 18, 2022 08:15 ET
|
ProPhase Labs, Inc.
May 23-26, 2022 (HYBRID CONFERENCE) Garden City, NY, May 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that...
ProPhase Labs Announces Record First Quarter 2022 Financial Results
May 13, 2022 08:30 ET
|
ProPhase Labs, Inc.
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per...
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
May 11, 2022 18:25 ET
|
ProPhase Labs, Inc.
Garden City, NY, May 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present at...